Chemistry:Acetoxymethylketobemidone
From HandWiki
Short description: Opioid designer drug
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C16H21NO3 |
| Molar mass | 275.348 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Acetoxymethylketobemidone (O-AMKD), is an opioid designer drug related to ketobemidone, with around the same potency as morphine. It was first identified in Germany in October 2020.[1][2]
See also
- 2F-Viminol
- 3-HO-PCP
- 4-Fluoropethidine
- Acetoxyketobemidone
- Bucinnazine
- Dipyanone
- Etodesnitazene
- Methylketobemidone
- Nortilidine
- O-Desmethyltramadol
- Piperidylthiambutene
- Propylketobemidone
References
- ↑ European Monitoring Center for Drugs and Drug Addiction (December 2020). "New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic.". An Update from the EU Early Warning System (Luxembourg: Publications Office of the European Union). doi:10.2810/921262. ISBN 9789294975584. https://www.emcdda.europa.eu/system/files/publications/13464/20205648_TD0320796ENN_PDF_rev.pdf.
- ↑ ""Etazene, safer than heroin and fentanyl": Non-fentanyl novel synthetic opioid listings on one darknet market". Drug and Alcohol Dependence 225: 108790. August 2021. doi:10.1016/j.drugalcdep.2021.108790. PMID 34091156.
 |  |
